Other
Net interest and investment income (loss)
West Pharmaceutical Services Net interest and investment income (loss) remained flat by 0.0% to $5.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 24.4%, from $4.10M to $5.10M. Over 4 years (FY 2021 to FY 2025), Net interest and investment income (loss) shows an upward trend with a 104.5% CAGR.
Analysis
StatementIncome Statement
SectionOther
First reportedQ1 2013
Last reportedQ1 2026Apr 23, 2026
Metric ID:
other_investment_income_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $200.00K | $400.00K | $300.00K | $300.00K | $400.00K | $1.50M | $2.90M | $4.80M | $5.00M | $8.80M | $9.40M | $6.20M | $4.00M | $4.60M | $4.80M | $4.10M | $3.60M | $4.70M | $5.10M | $5.10M |
| QoQ Change | — | +100.0% | -25.0% | +0.0% | +33.3% | +275.0% | +93.3% | +65.5% | +4.2% | +76.0% | +6.8% | -34.0% | -35.5% | +15.0% | +4.3% | -14.6% | -12.2% | +30.6% | +8.5% | +0.0% |
| YoY Change | — | — | — | — | +100.0% | +275.0% | +866.7% | >999% | >999% | +486.7% | +224.1% | +29.2% | -20.0% | -47.7% | -48.9% | -33.9% | -10.0% | +2.2% | +6.3% | +24.4% |
Range$200.00K – $9.40M
CAGR+97.7%
Avg YoY Growth+281.5%
Median YoY Growth+26.8%
Current Streak3 quarters growth
Net interest and investment income (loss) at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's net interest and investment income (loss)?
- West Pharmaceutical Services (WST) reported net interest and investment income (loss) of $5.10M in Q1 2026.
- How has West Pharmaceutical Services's net interest and investment income (loss) changed year-over-year?
- West Pharmaceutical Services's net interest and investment income (loss) increased by 24.4% year-over-year, from $4.10M to $5.10M.
- What is the long-term trend for West Pharmaceutical Services's net interest and investment income (loss)?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's net interest and investment income (loss) has grown at a 104.5% compound annual growth rate (CAGR), from $1.00M to $17.50M.